Nasal Decongestant Containing Bacteria Recalled

Posted on

A nasal decongestant has been recalled by Insight Pharmaceuticals after it was found the spray may contain bacteria, according to recent news sources.

About 34,092 bottles of Nostrilla are subject to recall. The product, which contains oxymetazoline, is used to relieve nasal suffering from colds.

The bacteria is called Burkholderia cepacia and is especially dangerous to those with weakened immunse systems or chronic lung conditions such as cystic fibrosis.

The product was distributed all over the U.S. and comes in a small, .5 ounce plastic bottle with an expiration day of May 2014.

If you purchased this product, you can return it for a full refund.
As a Los Angeles personal injury lawyer, if you or a loved one has been injured because of a contaminated or defective medical product or device, I suggest you seek medical attention right away. It can also be just as important to contact a product liability lawyer as soon as possible because you may be entitled to monetary compensation as a result of getting injured because of a defective or recalled product. You should also remember that the longer you take to contact someone about your case the more chance you have to lose evidence. Please visit this blog often to stay informed of new drug recalls and warnings.